Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Welcome to the Resolution Investors website.  Please read the below and confirm your understanding by clicking ‘Accept’ before proceeding.
 
The website https://resolutioninvestors.com is operated by Resolution Investors LLP (“Resolution”).  Resolution Investors LLP is a limited liability partnership registered in England and Wales. Registered number: OC454807. Resolution Investors LLP (FRN:1029032) is an appointed representative of Thornbridge Investment Management LLP (FRN: 713859) which is authorised and regulated by the Financial Conduct Authority.
 
The material contained on this site is directed at sophisticated investors (e.g. Professional Client, Accredited Investor) as defined in the applicable jurisdiction for the investor. If you are unsure of whether you are a sophisticated investor, you MUST NOT ACCESS THIS SITE. Certain products might not be available in all jurisdictions and the website and the information contained therein is not addressed to any person in any domicile territory or country where any such distribution would be against any applicable local law or regulation. It may also be against the law to use the website and its information in certain countries and Resolution, its partners and personnel disclaim any and all responsibility for any access carried out in breach of any law.
 
All persons accessing this site do so on an unsolicited basis and at their own initiative. The information contained on our site may be restricted in certain jurisdictions. It is the responsibility of persons accessing our site to inform themselves of, and act in accordance with, the legal and regulatory requirements in their jurisdiction of citizenship, residence or domicile. We and our partners disclaim all responsibility if persons access our site, or the information on it, contrary to such legal and regulatory requirements. This is not a contractually binding document. This material is being provided for informational purposes only and does not constitute investment advice and is not an offer or solicitation for investment. This document has only been issued to intended recipients, sophisticated investors as defined by local regulations and if this is not you, please disregard. This material is based on proprietary information of Resolution, is provided for reference only and is privileged and confidential.